TheProfitWatch

RNA - Avidity Biosciences, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
48.56 1.94 (4.0%) --- --- --- -0.36 (-0.74%) 2.29 (4.75%) -0.49 (-0.96%) -0.49 (-0.96%)

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-1.21
Diluted EPS:
-1.21
Basic P/E:
-41.7355
Diluted P/E:
-41.7355
RSI(14) 1m:
100.0
VWAP:
50.52
RVol:
0.6149

Events

Period Kind Movement Occurred At
1m Price increase 1m 51.49 +0.58 (+1.14%) Oct 15 14:09

Related News